Theriva Biologics, Inc. (TOVX)
NYSE: TOVX · CIK 0000894158 · United States
Every official Theriva Biologics, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open TOVX filings
Theriva Biologics, Inc. documents
- Theriva Biologics, Inc. 10-K 2026TOVX 10-K 2026: annual report for fiscal 2026
- Theriva Biologics, Inc. 10-K 2025TOVX 10-K 2025: annual report for fiscal 2025
- Theriva Biologics, Inc. 10-K 2024TOVX 10-K 2024: annual report for fiscal 2024
- Theriva Biologics, Inc. 10-K 2023TOVX 10-K 2023: annual report for fiscal 2023
- Theriva Biologics, Inc. 10-K 2022TOVX 10-K 2022: annual report for fiscal 2022
- Theriva Biologics, Inc. 10-Q 2026TOVX 10-Q 2026: quarterly report for fiscal 2026
- Theriva Biologics, Inc. 10-Q 2025TOVX 10-Q 2025: quarterly report for fiscal 2025
- Theriva Biologics, Inc. 10-Q 2024TOVX 10-Q 2024: quarterly report for fiscal 2024
- Theriva Biologics, Inc. 10-Q 2023TOVX 10-Q 2023: quarterly report for fiscal 2023
- Theriva Biologics, Inc. 10-Q 2022TOVX 10-Q 2022: quarterly report for fiscal 2022
- Theriva Biologics, Inc. 8-K 2026TOVX 8-K 2026: current report for fiscal 2026
- Theriva Biologics, Inc. 8-K 2025TOVX 8-K 2025: current report for fiscal 2025
- Theriva Biologics, Inc. 8-K 2024TOVX 8-K 2024: current report for fiscal 2024
- Theriva Biologics, Inc. 8-K 2023TOVX 8-K 2023: current report for fiscal 2023
- Theriva Biologics, Inc. 8-K 2022TOVX 8-K 2022: current report for fiscal 2022
- Theriva Biologics, Inc. DEF 14A 2026TOVX DEF 14A 2026: proxy statement for fiscal 2026
- Theriva Biologics, Inc. DEF 14A 2025TOVX DEF 14A 2025: proxy statement for fiscal 2025
- Theriva Biologics, Inc. DEF 14A 2024TOVX DEF 14A 2024: proxy statement for fiscal 2024
- Theriva Biologics, Inc. DEF 14A 2023TOVX DEF 14A 2023: proxy statement for fiscal 2023
- Theriva Biologics, Inc. DEF 14A 2022TOVX DEF 14A 2022: proxy statement for fiscal 2022
- Theriva Biologics, Inc. Form 4 2026TOVX Form 4 2026: insider trading filing for fiscal 2026
- Theriva Biologics, Inc. Form 4 2025TOVX Form 4 2025: insider trading filing for fiscal 2025
- Theriva Biologics, Inc. Form 4 2024TOVX Form 4 2024: insider trading filing for fiscal 2024
- Theriva Biologics, Inc. Form 4 2023TOVX Form 4 2023: insider trading filing for fiscal 2023
- Theriva Biologics, Inc. Form 4 2022TOVX Form 4 2022: insider trading filing for fiscal 2022
- Theriva Biologics, Inc. S-1 2026TOVX S-1 2026: registration statement for fiscal 2026
- Theriva Biologics, Inc. S-1 2025TOVX S-1 2025: registration statement for fiscal 2025
- Theriva Biologics, Inc. S-1 2024TOVX S-1 2024: registration statement for fiscal 2024
- Theriva Biologics, Inc. S-1 2023TOVX S-1 2023: registration statement for fiscal 2023
- Theriva Biologics, Inc. S-1 2022TOVX S-1 2022: registration statement for fiscal 2022
- Theriva Biologics, Inc. 13F 2026TOVX 13F 2026: institutional holdings for fiscal 2026
- Theriva Biologics, Inc. 13F 2025TOVX 13F 2025: institutional holdings for fiscal 2025
- Theriva Biologics, Inc. 13F 2024TOVX 13F 2024: institutional holdings for fiscal 2024
- Theriva Biologics, Inc. 13F 2023TOVX 13F 2023: institutional holdings for fiscal 2023
- Theriva Biologics, Inc. 13F 2022TOVX 13F 2022: institutional holdings for fiscal 2022
More companies